{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:24:43Z","timestamp":1756995883323},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1988,9,1]],"date-time":"1988-09-01T00:00:00Z","timestamp":589075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[1988,9]]},"DOI":"10.1016\/0002-9149(88)90657-1","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T12:30:11Z","timestamp":1082723411000},"page":"571-575","source":"Crossref","is-referenced-by-count":27,"title":["Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction"],"prefix":"10.1016","volume":"62","member":"78","reference":[{"key":"10.1016\/0002-9149(88)90657-1_BIB1","first-page":"23","article-title":"Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia","volume":"98","author":"Horowitz","year":"1980","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/0002-9149(88)90657-1_BIB2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJM197508072930601","article-title":"Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation","volume":"293","author":"Schaffer","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/0002-9149(88)90657-1_BIB3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jama.1984.03350050061030","article-title":"Premature ventricular complexes: diagnosis and indications for therapy","volume":"252","author":"Morganroth","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/0002-9149(88)90657-1_BIB4","doi-asserted-by":"crossref","first-page":"8B","DOI":"10.1016\/0002-9149(84)90494-6","article-title":"Antiarrhythmic drug treatment. An overview","volume":"53","author":"Bigger","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9149(81)90344-1","article-title":"Prevalence, characteristics and significance of ventricular tachycardia detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction","volume":"48","author":"Bigger","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0002-9149(86)90374-7","article-title":"Prevalence, characteristics, and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographs recordings in the late hospital phase of myocardial infarction","volume":"50","author":"Bigger","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9149(82)90319-8","article-title":"Can we prevent sudden cardiac death?","volume":"50","author":"Horowitz","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB8","doi-asserted-by":"crossref","first-page":"74C","DOI":"10.1016\/0002-9149(86)90108-6","article-title":"Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials","volume":"58","author":"Morganroth","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0735-1097(86)80251-0","article-title":"Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias","volume":"7","author":"Morganroth","year":"1986","journal-title":"JACC"},{"key":"10.1016\/0002-9149(88)90657-1_BIB10","doi-asserted-by":"crossref","first-page":"32E","DOI":"10.1016\/0002-9149(87)90199-8","article-title":"Risk factors for the development of proarrhythmic events","volume":"59","author":"Morganroth","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB11","doi-asserted-by":"crossref","first-page":"89B","DOI":"10.1016\/0002-9149(84)90509-5","article-title":"Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram","volume":"53","author":"Morganroth","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0735-1097(86)80190-5","article-title":"Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide","volume":"8","author":"Morganroth","year":"1986","journal-title":"JACC"},{"key":"10.1016\/0002-9149(88)90657-1_BIB13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0002-9149(86)90208-0","article-title":"Treatment of resistant ventricular tachycardia with flecainide acetate","volume":"57","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.CIR.63.3.670","article-title":"Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia","volume":"63","author":"Mason","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/0002-9149(88)90657-1_BIB15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0002-9149(83)90014-0","article-title":"Encainide for refractory ventricular tachyarrhythmia","volume":"52","author":"Chesnie","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB16","doi-asserted-by":"crossref","first-page":"83C","DOI":"10.1016\/0002-9149(86)90109-8","article-title":"Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms","volume":"58","author":"Horowitz","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/0002-9149(88)90657-1_BIB17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0735-1097(87)80096-7","article-title":"Influence of left ventricular dysfunction on flecainide therapy","volume":"9","author":"dePaola","year":"1987","journal-title":"JACC"},{"key":"10.1016\/0002-9149(88)90657-1_BIB18","first-page":"IV","article-title":"Risk factors and incidence of proarrhythmia from the use of moricizine (ethmozine) in ventricular arrhythmias (abstr)","volume":"76","author":"Morganroth","year":"1987","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002914988906571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0002914988906571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T08:01:35Z","timestamp":1549785695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0002914988906571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1988,9]]}},"alternative-id":["0002914988906571"],"URL":"https:\/\/doi.org\/10.1016\/0002-9149(88)90657-1","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[1988,9]]}}}